Sumitomo Mitsui Trust Holdings, Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $168 Billion
- Q3 2025
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 307,289 shares of REGN stock, worth $213 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
307,289
Previous 308,185
0.29%
Holding current value
$213 Million
Previous $162 Million
6.79%
% of portfolio
0.1%
Previous 0.1%
Shares
34 transactions
Others Institutions Holding REGN
# of Institutions
1,490Shares Held
86.4MCall Options Held
2.38MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA9.05MShares$6.27 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.86 Billion0.2% of portfolio
-
State Street Corp Boston, MA4.69MShares$3.25 Billion0.09% of portfolio
-
Dodge & Cox San Francisco, CA4.55MShares$3.16 Billion1.47% of portfolio
-
Jpmorgan Chase & CO New York, NY4.07MShares$2.82 Billion0.15% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $74.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...